{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:36:22Z","timestamp":1779309382229,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001469","name":"Singapore General Hospital","doi-asserted-by":"publisher","award":["000"],"award-info":[{"award-number":["000"]}],"id":[{"id":"10.13039\/501100001469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00198-020-05536-4","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T11:44:33Z","timestamp":1597405473000},"page":"133-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of FRAX\u00ae-based intervention thresholds for management of osteoporosis in Singaporean women"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-8443","authenticated-orcid":false,"given":"M.","family":"Chandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.B.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"9","key":"5536_CR1","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00198-015-3154-6","volume":"26","author":"A Od\u00e9n","year":"2015","unstructured":"Od\u00e9n A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int 26(9):2243\u20132248","journal-title":"Osteoporos Int"},{"key":"5536_CR2","unstructured":"https:\/\/population.un.org\/wpp\/Publications\/Files\/WPP2017_KeyFindings.pdf. Last accessed April 26 2020"},{"issue":"1","key":"5536_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","volume":"4","author":"CL Cheung","year":"2018","unstructured":"Cheung CL, Ang SB, Chadha M, Chow ESL, Chung YS, Hew FL, Jaisamrarn U, Ng H, Takeuchi Y, Wu CH, Xia W, Yu J, Fujiwara S (2018) An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study. Osteoporosis and sarcopenia 4(1):16\u201321","journal-title":"Osteoporosis and sarcopenia"},{"issue":"7","key":"5536_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00198-017-3985-4","volume":"28","author":"NA Mohd-Tahir","year":"2017","unstructured":"Mohd-Tahir NA, Li SC (2017) Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int 28(7):2035\u20132044","journal-title":"Osteoporos Int"},{"key":"5536_CR5","unstructured":"https:\/\/www.singstat.gov.sg\/modules\/infographics\/economy. Last Accessed December 1 2019"},{"issue":"1","key":"5536_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11657-019-0664-4","volume":"14","author":"M Chandran","year":"2019","unstructured":"Chandran M, Lau TC, Gagnon-Arpin I, Dobrescu A, Li W, Leung MYM, Patil N, Zhao Z (2019) The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options. Arch Osteoporos 14(1):114","journal-title":"Arch Osteoporos"},{"key":"5536_CR7","unstructured":"(https:\/\/www.aihw.gov.au\/reports\/chronic-musculoskeletal-conditions\/snapshot-of-osteoporosis-australia-2011. Last accessed April 26 2020"},{"issue":"5","key":"5536_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513\u2013521","journal-title":"JAMA"},{"issue":"1","key":"5536_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00198-003-1490-4","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Od\u00e9n A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15(1):38","journal-title":"Osteoporos Int"},{"issue":"3","key":"5536_CR10","first-page":"401","volume":"59","author":"R Malhotra","year":"2019","unstructured":"Malhotra R, Bautista MAC, M\u00fcller AM, Aw S, Koh GCH, Theng YL, Hoskins SJ, Wong CH, Miao C, Lim WS, Malhotra C, Chan A (2019) The aging of a young nation: population aging in Singapore. Gerontologist May 59(3):401\u2013410","journal-title":"Gerontologist May"},{"issue":"5","key":"5536_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S8756-3282(00)00381-1","volume":"27","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A et al (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27(5):585\u2013590","journal-title":"Bone"},{"issue":"22","key":"5536_CR12","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","volume":"286","author":"ES Siris","year":"2001","unstructured":"Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286(22):2815\u20132822","journal-title":"JAMA"},{"issue":"3","key":"5536_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2017.06.010","volume":"20","author":"M Chandran","year":"2017","unstructured":"Chandran M (2017) Fracture risk assessment in clinical practice: why do it? What to do it with? J Clin Densitom 20(3):274\u2013279","journal-title":"J Clin Densitom"},{"issue":"1","key":"5536_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Archives of Osteoporos 11(1):25","journal-title":"Archives of Osteoporos"},{"issue":"4","key":"5536_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"ANA Tosteson","year":"2008","unstructured":"Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437\u2013447","journal-title":"Osteoporos Int"},{"issue":"10","key":"5536_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A et al (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395\u20131408","journal-title":"Osteoporos Int"},{"issue":"11","key":"5536_CR17","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstr\u00f6m F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX\u00ae in Switzerland. Osteoporos Int 23(11):2579\u20132589","journal-title":"Osteoporos Int"},{"issue":"1","key":"5536_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11657-018-0542-5","volume":"13","author":"M Chandran","year":"2018","unstructured":"Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D et al (2018) FRAX\u00ae based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13(1):130","journal-title":"Arch Osteoporos"},{"issue":"2","key":"5536_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey E, Reid DM, Selby P, Wilkins M, National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62(2):105\u2013108","journal-title":"Maturitas"},{"issue":"3","key":"5536_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148(3):197\u2013213","journal-title":"Ann Intern Med"},{"issue":"5","key":"5536_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1524-4733.2008.00497.x","volume":"12","author":"M Hiligsmann","year":"2009","unstructured":"Hiligsmann M, Ethgen O, Bruy\u00e8re O, Richy F, Gathon HJ, Reginster JY et al (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 12(5):687\u2013696","journal-title":"Value Health"},{"issue":"2","key":"5536_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semarthrit.2019.01.006","volume":"49","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster JY et al (2019) Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture. Semin Arthritis Rheum 49(2):184\u2013196","journal-title":"Semin Arthritis Rheum"},{"key":"5536_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.vhri.2018.03.007","volume":"18","author":"F Pearce","year":"2019","unstructured":"Pearce F, Lin L, TeoEl NK, Khoo D (2019) Health technology assessment and its use in drug policies: Singapore. Value in Health regional issues 18:176\u2013183","journal-title":"Value in Health regional issues"},{"issue":"1","key":"5536_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00198-018-4744-x","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT, Halbout P, Jiwa F, Lewiecki EM, Pinto D, Adachi JD, al-Daghri N, Bruy\u00e8re O, Chandran M, Cooper C, Harvey NC, Einhorn TA, Kanis JA, Kendler DL, Messina OD, Rizzoli R, Si L, Silverman S (2019) Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts\u2019 consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. Osteoporos Int 30(1):45\u201357","journal-title":"Osteoporos Int"},{"issue":"4","key":"5536_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00198-019-04839-5","volume":"30","author":"EL Yong","year":"2019","unstructured":"Yong EL, Ganesan G, Kramer MS, Logan S, Lau TC, Cauley JA, Tan KB (2019) Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium. Osteoporos Int 30(4):879\u2013886","journal-title":"Osteoporos Int"},{"key":"5536_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures; a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"5536_CR27","doi-asserted-by":"crossref","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone35:375\u2013382","DOI":"10.1016\/j.bone.2004.03.024"},{"key":"5536_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00198-003-1514-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Oden A et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175\u2013179","journal-title":"Osteoporos Int"},{"key":"5536_CR29","unstructured":"DOS mortality rates. https:\/\/singstat.gov.sg\/publicfacing\/createDataTable.action?refid=13249 Last Accessed 1 Dec 2019"},{"key":"5536_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0033-3506(05)80614-6","volume":"105","author":"MJ Parker","year":"1991","unstructured":"Parker MJ, Anand JK (1991) What is the true mortality of hip fracture? Public Health 105:443\u2013446","journal-title":"Public Health"},{"issue":"3","key":"5536_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00198-017-4317-4","volume":"29","author":"A Svedbom","year":"2018","unstructured":"Svedbom A, Borgst\u00f6m F, Hernlund E, Str\u00f6m O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, J\u00fcrisson M, Kallikorm R, Lember M, Lesnyak O, McCloskey E, Sanders KM, Silverman S, Solodovnikov A, Tamulaitiene M, Thomas T, Toroptsova N, Uusk\u00fcla A, Tosteson ANA, J\u00f6nsson B, Kanis JA (2018) Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS. Osteoporos Int 29(3):557\u2013566","journal-title":"Osteoporos Int"},{"issue":"4","key":"5536_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-008-9117-6","volume":"82","author":"M Hiligsmann","year":"2008","unstructured":"Hiligsmann M, Ethgen O, Richy F, Reginster JY (2008) Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 82(4):288\u2013292","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"5536_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0272989X06290497","volume":"26","author":"J Hanmer","year":"2006","unstructured":"Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG (2006) Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Mak 26(4):391\u2013400","journal-title":"Med Decis Mak"},{"issue":"12","key":"5536_CR34","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.clinthera.2011.10.021","volume":"33","author":"SW Wade","year":"2011","unstructured":"Wade SW, Satram-Hoang S, Nadkar A, Macarios D, Tosteson ANA (2011) Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy. Clin Ther 33(12):2006\u20132015","journal-title":"Clin Ther"},{"issue":"3","key":"5536_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00198-011-1635-9","volume":"23","author":"MH Cheen","year":"2012","unstructured":"Cheen MH, Kong MC, Zhang RF, Tee FM, Chandran M (2012) Adherence to osteoporosis medications amongst Singaporean patients. Osteoporos Int Mar 23(3):1053\u20131060","journal-title":"Osteoporos Int Mar"},{"issue":"2","key":"5536_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/erp.12.8","volume":"12","author":"M Hiligsmann","year":"2012","unstructured":"Hiligsmann M, Boonen A, Rabenda V, Reginster JY (2012) The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert review of pharmacoeconomics & outcomes research 12(2):159\u2013166","journal-title":"Expert review of pharmacoeconomics & outcomes research"},{"key":"5536_CR37","unstructured":"National Institute for Health and Clinical Excellence (NICE). Systematic reviews of clinical effectiveness prepared for the guideline \u201cOsteoporosis assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk https:\/\/www.nice.org.uk\/guidance\/ta464\/chapter\/3-Committee-discussion#clinical-effectiveness Last accessed December 1 2019"},{"issue":"3","key":"5536_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40273-014-0231-1","volume":"33","author":"M Hiligsmann","year":"2015","unstructured":"Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 33(3):205\u2013224","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"5536_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00198-014-2900-5","volume":"26","author":"O Str\u00f6m","year":"2015","unstructured":"Str\u00f6m O, Landfeldt E, Garellick G (2015) Residual effect after oral bisphosphonate treatment and healthy adherer effects--the Swedish Adherence Register Analysis (SARA). Osteoporos Int 26(1):315\u2013325","journal-title":"Osteoporos Int"},{"issue":"5","key":"5536_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jval.2012.02.001","volume":"15","author":"M Hiligsmann","year":"2012","unstructured":"Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY (2012) The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health 15(5):604\u2013612","journal-title":"Value Health"},{"issue":"4","key":"5536_CR41","doi-asserted-by":"publisher","first-page":"e027049","DOI":"10.1136\/bmjopen-2018-027049","volume":"9","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049","journal-title":"BMJ Open"},{"key":"5536_CR42","unstructured":"World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE): cost effectiveness thresholds. http:\/\/www.who.int\/choice\/costs\/CER_thresholds\/en\/ Last accessed December 1 2019"},{"issue":"3","key":"5536_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jfma.2016.03.006","volume":"116","author":"DC Chan","year":"2017","unstructured":"Chan DC, McCloskey EV, Chang CB, Lin KP, Lim LC, Tsai KS, Yang RS (2017) Establishing and evaluating FRAX\u00ae probability thresholds in Taiwan. J Formos Med Assoc Mar 116(3):161\u2013168","journal-title":"J Formos Med Assoc Mar"},{"issue":"10109","key":"5536_CR44","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(17)32850-7","volume":"390","author":"NC Harvey","year":"2017","unstructured":"Harvey NC, McCloskey E, Kanis JA, Compston J, Cooper C (2017) Bisphosphonates in osteoporosis: NICE and easy? Lancet 390(10109):2243\u20132244","journal-title":"Lancet"},{"key":"5536_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11657-010-0045-5","volume":"5","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, McCloskey E, Johnson B, Cooper A, Strom O, Borgstrom F (2010) An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women. Archives of Osteoporosis 5:19\u201348","journal-title":"Archives of Osteoporosis"},{"key":"5536_CR46","unstructured":"https:\/\/iofbonehealth.org\/data-publications\/regionalaudits\/asia-pacific-regionalaudit. Last accessed April 26 2020"},{"key":"5536_CR47","doi-asserted-by":"publisher","unstructured":"Chandran M, Chin YA, Choo KS, Ang WC et al (2020) Comparison of the osteoporosis self-assessment tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: aA discriminatory value analysis in a multi-ethnic female population in Southeast Asia. Osteoporosis and Sarcopenia. https:\/\/doi.org\/10.1016\/j.afos.2020.04.001","DOI":"10.1016\/j.afos.2020.04.001"},{"key":"5536_CR48","unstructured":"Chandran M, Ang SB, Au L, et al. (2018) Appropriate care guide: osteoporosis identification and management in primary care. Singapore: Ministry of Health. http:\/\/www.ace-hta.gov.sg\/our-guidance\/osteoporosis-identification-and-management-in-primary-care.html. Last accessed April 26 2020"},{"issue":"1","key":"5536_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00198-011-1796-6","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Reginster JY, Kaufman JM, Ringe JD, Adachi JD, Hiligsmann M, Rizzoli R, Cooper C (2012) A reappraisal of generic bisphosphonates in osteoporosis. Osteoporos Int 23(1):213\u2013221","journal-title":"Osteoporos Int"},{"issue":"1","key":"5536_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2007.10.019","volume":"42","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Adams J, Borgstrom F, Cooper C, Johnson B, Preedy D, Selby P, Compston J (2007) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42(1):4\u2013115","journal-title":"Bone"},{"key":"5536_CR51","unstructured":"https:\/\/southeastasiaglobe.com\/how-southeast-asian-countries-compare-growth-development\/. Last accessed April 26 2020"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05536-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T23:12:11Z","timestamp":1628896331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05536-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5536"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05536-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}